AnaptysBio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 44.26 million compared to USD 36.26 million a year ago. Basic loss per share from continuing operations was USD 1.58 compared to USD 1.31 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.6 USD | +1.35% | -0.58% | +19.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.51% | 699M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023